Login / Signup

Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus.

Carla UsaiUpkar S GillAnna C RiddellTarik AsselahPatrick T F Kennedy
Published in: Alimentary pharmacology & therapeutics (2022)
The HBV cure programme potentially offers a unique opportunity to enhance HDV treatment strategies. In addition, a more comprehensive analysis of the intrahepatic compartment is mandated to better understand any liver-confined interaction of HDV with the host immune system.
Keyphrases
  • hepatitis b virus
  • study protocol
  • liver failure
  • randomized controlled trial
  • clinical trial
  • double blind